DXA utilization between 2006 and 2012 in commercially insured younger postmenopausal women

Journal of Clinical Densitometry

Volumn 18, Issue 2, 2015, Pages 145-149

  Overman, Robert A ^a,b   Farley, Joel F ^a   Curtis, Jeffrey R ^c   Zhang, Jie ^d   Gourlay, Margaret L ^e   Deal, Chad L ^b  

^a UNC Hamner Institute for Drug Safety Sciences   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Dual energy x ray absorptiometry (DXA); Osteoporosis; Reimbursement; Utilization

Indexed keywords

ADULT; ARTICLE; CLINICAL EVALUATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MEDICARE; POSTMENOPAUSE; PRIORITY JOURNAL; REIMBURSEMENT; ECONOMICS; HEALTH INSURANCE; MIDDLE AGED; PHOTON ABSORPTIOMETRY; POSTMENOPAUSE OSTEOPOROSIS; RADIOGRAPHY; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES; UTILIZATION;

ABSORPTIOMETRY, PHOTON; FEMALE; HUMANS; INSURANCE, HEALTH; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; REGRESSION ANALYSIS; REIMBURSEMENT MECHANISMS; UNITED STATES;

EID: 84928772187     PISSN: 10946950     EISSN: 15590747     Source Type: Journal    
DOI: 10.1016/j.jocd.2015.01.005     Document Type: Article

References (18)

1. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994, 843:1-129. World Health Organization.
2. Siris E.S., Adler R., Bilezikian J., et al. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int 2014, 25:1439-1443.
3. Wright N.C., Looker A.C., Saag K.G., et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 2014, 29(11):2520-2526.
4. Elliot-Gibson V., Bogoch E.R., Jamal S.A., Beaton D.E. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 2004, 15:767-778.
5. Medicare program; Medicare coverage of and payment for bone mass measurements. Interim final rule with comment period. Fed Regist 1998, 63:34320-34328. Health Care Financing Administration, Department of Health and Human Services (US).
6. King A.B., Fiorentino D.M. Medicare payment cuts for osteoporosis testing reduced use despite tests' benefit in reducing fractures. Health Aff (Millwood) 2011, 30:2362-2370.
7. Lewin Group Inc. 2007 Assessing the costs of performing DXA services in the office-based setting. Falls Church, VA: Lewin Group.
8. Centers for Medicare & Medicaid Services. Department of Health and Human Services (US) 2009 Medicare Program; payment policies under the Physician Fee Schedule and Other Revisions to Part B for CY. 2010. CMS-1413-P. Fed Regist 74:33520-33825. Available at: Accessed: September 29,2014. http://edocket.access.gpo.gov/2009/pdf/E9-15835.pdf.
9. International Society for Clinical Densitometry. 2009. Update on DXA in DC CMS proposes more cuts; DXA Bill Gains Sponsors. Available at: Accessed: September 29,2014. http://www.iscd.org/dxa-reimbursement-issues/update-on-dxa-in-dc-cms-proposes-more-cuts-dxa-bill-gains-sponsors.
10. Boyle A.M. Bone density tests strengthen bottom line 2012, Medical Economics, Available at:. http://medicaleconomics.modernmedicine.com/medical-economics/news/modernmedicine/modern-medicine-feature-articles/bone-density-tests-strengthen.
11. Zhang J., Delzell E., Zhao H., et al. Central DXA utilization shifts from office-based to hospital-based settings among Medicare beneficiaries in the wake of reimbursement changes. J Bone Miner Res 2012, 27:858-864.
12. Morden N.E., Schpero W.L., Zaha R., et al. Overuse of short-interval bone densitometry: assessing rates of low-value care. Osteoporos Int 2014, 25(9):2307-2311.
13. McAdam-Marx C., Unni S., Ye X., et al. Effect of Medicare reimbursement reduction for imaging services on osteoporosis screening rates. J Am Geriatr Soc 2012, 60:511-516.
14. O'Malley C.D., Johnston S.S., Lenhart G., et al. Trends in dual-energy X-ray absorptiometry in the United States, 2000-2009. J Clin Densitom 2011, 14(2):100-107.
15. Hansen L, Chang S. 2013. White paper: health research data for the real world: The Marketscan(R) Databases. Available at: Accessed February 11, 2015. http://truvenhealth.com/Portals/0/Users/031/31/31/PH_13434%200314_MarketScan_WP_web.pdf.
16. Overman R.A., Freburger J.K., Assimon M.M., et al. Observation stays in administrative claims databases: underestimation of hospitalized cases. Pharmacoepidemiol Drug Saf 2014, 23:902-910.
17. Wagner A.K., Soumerai S.B., Zhang F., Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002, 27:299-309.
18. Farley J.F., Dusetzina S.B. Medicaid prescription drug utilization and expenditures following Part D. J Health Care Poor Underserved 2010, 21:715-728.